Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
0 hedge funds and large institutions have $0 invested in Inhibrx, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.16M → $0 (-$1.16M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$928K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$228K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$928K | -26,400 | Closed |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| – | -$228K | -6,690 | Closed |
|
INBX Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q3 2024, worth a combined $0 — down 100% from $1.16M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of INBX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $928K sold.
- 0 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q3 2024, down from 2 in Q2 2024.
- Funds reported $0 of Inhibrx, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Inhibrx, Inc. Common Stock positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest Inhibrx, Inc. Common Stock seller in Q3 2024 was DekaBank Deutsche Girozentrale, an estimated $928K sold.
Based on aggregated 13F filings for Q3 2024.